药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tenamfetamine
Synthetic Conjugated Estrogens, A
Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Betrixaban.
Tenamfetamine
Hexestrol
Hexestrol may decrease the anticoagulant activities of Betrixaban.
Tenamfetamine
Quinestrol
Quinestrol may decrease the anticoagulant activities of Betrixaban.
Tenamfetamine
Tibolone
Tibolone may increase the anticoagulant activities of Betrixaban.
Tenamfetamine
Sugammadex
The risk or severity of bleeding and hemorrhage can be increased when Betrixaban is combined with Sugammadex.
Tenamfetamine
Obinutuzumab
The risk or severity of bleeding and hemorrhage can be increased when Betrixaban is combined with Obinutuzumab.
Tenamfetamine
Ibrutinib
The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Betrixaban.
Tenamfetamine
Hyodeoxycholic Acid
The risk or severity of bleeding and bruising can be increased when Betrixaban is combined with Hyodeoxycholic Acid.
Tenamfetamine
Dehydrocholic acid
The risk or severity of bleeding and bruising can be increased when Betrixaban is combined with Dehydrocholic acid.
Tenamfetamine
Chenodeoxycholic acid
The risk or severity of bleeding and bruising can be increased when Betrixaban is combined with Chenodeoxycholic acid.
Tenamfetamine
Deferasirox
The risk or severity of gastrointestinal bleeding can be increased when Betrixaban is combined with Deferasirox.
1-Phenylcyclohexylamine
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Satralizumab
The serum concentration of Rucaparib can be decreased when it is combined with Satralizumab.
1-Phenylcyclohexylamine
Oliceridine
The serum concentration of Oliceridine can be increased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Abametapir
The serum concentration of Rucaparib can be increased when it is combined with Abametapir.
1-Phenylcyclohexylamine
Sacituzumab govitecan
The serum concentration of Sacituzumab govitecan can be increased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Ozanimod
Rucaparib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
1-Phenylcyclohexylamine
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Rucaparib.